Synthesis and biological activity of LH-RH analogs modified at the carboxyl terminus

David H. Coy, Esther J. Coy, Andrew V Schally, Jesus A. Vilchez-Martinez

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Des(Pro9,Gly10)-LH-RH ethylamide, des(Pro9,Gly10)-LH-RH butylamide, desGly10-LH-RH 2-aminoethylamide, and desGly10-LH-RH hydrazide were synthesized by a solid-phase method involving cleavage of protected peptide intermediates from their resin support by reaction with ethylamine, butylamine, ethylenediamine, and hydrazine, respectively. In the assay utilizing steroid pretreated, ovariectomized rats, the peptides were found to have the following LH-releasing activities when compared with natural LH-RH: ethylamide, 0.2%; butylamide, 0.1%; 2-aminoethylamide, 2.4%; hydrazide, 12%. DesGly10-LH-RH hydrazide was used as a precursor in the synthesis of desGly10-LH-RH allylamide and desGly10-LH-RH propargylamide by conversion to the azide and reaction with allylamine and propargylamine, respectively. LH and FSH levels were measured over a 4-hr period after subcutaneous injection of these two peptides into immature male rats in order to detect any prolongation of activity. The allylamide analog was quite active, releasing 1.7 times more LH and 1.3 times more FSH than the same dose of LH-RH. The propargylamide analog was considerably less active, exhibiting 50% LH-releasing activity and 64% FSH-releasing activity. Neither peptic e appeared to be longer acting than LH-RH.

Original languageEnglish
Pages (from-to)275-277
Number of pages3
JournalJournal of Medicinal Chemistry
Volume18
Issue number3
StatePublished - Dec 1 1975
Externally publishedYes

Fingerprint

Bioactivity
Gonadotropin-Releasing Hormone
ethylenediamine
hydrazine
Peptides
Rats
Butylamines
Allylamine
Azides
Subcutaneous Injections
Digestion
Assays
Resins
Steroids

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Synthesis and biological activity of LH-RH analogs modified at the carboxyl terminus. / Coy, David H.; Coy, Esther J.; Schally, Andrew V; Vilchez-Martinez, Jesus A.

In: Journal of Medicinal Chemistry, Vol. 18, No. 3, 01.12.1975, p. 275-277.

Research output: Contribution to journalArticle

Coy, David H. ; Coy, Esther J. ; Schally, Andrew V ; Vilchez-Martinez, Jesus A. / Synthesis and biological activity of LH-RH analogs modified at the carboxyl terminus. In: Journal of Medicinal Chemistry. 1975 ; Vol. 18, No. 3. pp. 275-277.
@article{9ed338313a484ec184b4a9038a2cc88f,
title = "Synthesis and biological activity of LH-RH analogs modified at the carboxyl terminus",
abstract = "Des(Pro9,Gly10)-LH-RH ethylamide, des(Pro9,Gly10)-LH-RH butylamide, desGly10-LH-RH 2-aminoethylamide, and desGly10-LH-RH hydrazide were synthesized by a solid-phase method involving cleavage of protected peptide intermediates from their resin support by reaction with ethylamine, butylamine, ethylenediamine, and hydrazine, respectively. In the assay utilizing steroid pretreated, ovariectomized rats, the peptides were found to have the following LH-releasing activities when compared with natural LH-RH: ethylamide, 0.2{\%}; butylamide, 0.1{\%}; 2-aminoethylamide, 2.4{\%}; hydrazide, 12{\%}. DesGly10-LH-RH hydrazide was used as a precursor in the synthesis of desGly10-LH-RH allylamide and desGly10-LH-RH propargylamide by conversion to the azide and reaction with allylamine and propargylamine, respectively. LH and FSH levels were measured over a 4-hr period after subcutaneous injection of these two peptides into immature male rats in order to detect any prolongation of activity. The allylamide analog was quite active, releasing 1.7 times more LH and 1.3 times more FSH than the same dose of LH-RH. The propargylamide analog was considerably less active, exhibiting 50{\%} LH-releasing activity and 64{\%} FSH-releasing activity. Neither peptic e appeared to be longer acting than LH-RH.",
author = "Coy, {David H.} and Coy, {Esther J.} and Schally, {Andrew V} and Vilchez-Martinez, {Jesus A.}",
year = "1975",
month = "12",
day = "1",
language = "English",
volume = "18",
pages = "275--277",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Synthesis and biological activity of LH-RH analogs modified at the carboxyl terminus

AU - Coy, David H.

AU - Coy, Esther J.

AU - Schally, Andrew V

AU - Vilchez-Martinez, Jesus A.

PY - 1975/12/1

Y1 - 1975/12/1

N2 - Des(Pro9,Gly10)-LH-RH ethylamide, des(Pro9,Gly10)-LH-RH butylamide, desGly10-LH-RH 2-aminoethylamide, and desGly10-LH-RH hydrazide were synthesized by a solid-phase method involving cleavage of protected peptide intermediates from their resin support by reaction with ethylamine, butylamine, ethylenediamine, and hydrazine, respectively. In the assay utilizing steroid pretreated, ovariectomized rats, the peptides were found to have the following LH-releasing activities when compared with natural LH-RH: ethylamide, 0.2%; butylamide, 0.1%; 2-aminoethylamide, 2.4%; hydrazide, 12%. DesGly10-LH-RH hydrazide was used as a precursor in the synthesis of desGly10-LH-RH allylamide and desGly10-LH-RH propargylamide by conversion to the azide and reaction with allylamine and propargylamine, respectively. LH and FSH levels were measured over a 4-hr period after subcutaneous injection of these two peptides into immature male rats in order to detect any prolongation of activity. The allylamide analog was quite active, releasing 1.7 times more LH and 1.3 times more FSH than the same dose of LH-RH. The propargylamide analog was considerably less active, exhibiting 50% LH-releasing activity and 64% FSH-releasing activity. Neither peptic e appeared to be longer acting than LH-RH.

AB - Des(Pro9,Gly10)-LH-RH ethylamide, des(Pro9,Gly10)-LH-RH butylamide, desGly10-LH-RH 2-aminoethylamide, and desGly10-LH-RH hydrazide were synthesized by a solid-phase method involving cleavage of protected peptide intermediates from their resin support by reaction with ethylamine, butylamine, ethylenediamine, and hydrazine, respectively. In the assay utilizing steroid pretreated, ovariectomized rats, the peptides were found to have the following LH-releasing activities when compared with natural LH-RH: ethylamide, 0.2%; butylamide, 0.1%; 2-aminoethylamide, 2.4%; hydrazide, 12%. DesGly10-LH-RH hydrazide was used as a precursor in the synthesis of desGly10-LH-RH allylamide and desGly10-LH-RH propargylamide by conversion to the azide and reaction with allylamine and propargylamine, respectively. LH and FSH levels were measured over a 4-hr period after subcutaneous injection of these two peptides into immature male rats in order to detect any prolongation of activity. The allylamide analog was quite active, releasing 1.7 times more LH and 1.3 times more FSH than the same dose of LH-RH. The propargylamide analog was considerably less active, exhibiting 50% LH-releasing activity and 64% FSH-releasing activity. Neither peptic e appeared to be longer acting than LH-RH.

UR - http://www.scopus.com/inward/record.url?scp=0016613630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016613630&partnerID=8YFLogxK

M3 - Article

C2 - 1094115

AN - SCOPUS:0016613630

VL - 18

SP - 275

EP - 277

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 3

ER -